Prosecution Insights
Last updated: April 19, 2026

Astellas Institute for Regenerative Medicine

5 pending office actions

Portfolio Summary

5
Total Pending OAs
2
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18504238 METHODS OF PRODUCING HUMAN RPE CELLS AND PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS BERTOGLIO, VALARIE E 1632 Final Rejection Nov 08, 2023
18472176 MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA KELLY, ROBERT M 1638 Non-Final OA Sep 21, 2023
18363663 MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA VIJAYARAGHAVAN, JAGAMYA NMN 1633 Non-Final OA Aug 01, 2023
18080134 HEMANGIO-COLONY FORMING CELLS FOX, ALLISON M 1633 Non-Final OA Dec 13, 2022
16669931 METHOD OF GENERATING NATURAL KILLER CELLS AND DENDRITIC CELLS FROM HUMAN EMBRYONIC STEM CELL-DERIVED HEMANGIOBLASTS MOSS, NATALIE M 1653 Final Rejection Oct 31, 2019

Managing Astellas Institute for Regenerative Medicine's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month